GLP1 usage is reshaping consumption The US market is leading the way when it comes to GLP-1 usage, with an estimated 18% of the population having used or currently using the medication
Forzano I, Varzideh F, Avvisato R, Jankauskas SS, Mone P, Santulli G
Acknowledgments All the pictures in this article are drawn in Adobe Illustrator 2023, thanks to the support provided by the software
Scientific Evidence and Studies Key Clinical Trials on Semaglutide and Kidney Health: Several landmark studies have provided evidence of Semaglutides kidney-protective benefits: SUSTAIN Trials: These trials focused on the cardiovascular and renal outcomes of Semaglutide in patients with Type 2 diabetes
Vitamin B12 Injection is often supplied as cyanocobalamin injection 1000 mcg/mL, also written as 1,000 mcg per mL
Systematic adverse event collection would inform risk-benefit assessment and identify any previously unrecognized safety concerns